Arialys Therapeutics
San Diego, United States· Est.
Arialys Therapeutics focuses on developing autoimmune and neuroinflammatory disease treatments by targeting pathogenic antibodies in the central nervous system.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Total funding raised: $58M
About
Arialys Therapeutics focuses on developing autoimmune and neuroinflammatory disease treatments by targeting pathogenic antibodies in the central nervous system.
NeuroscienceImmunologyAntibodies
Funding History
1Total raised:$58M
Grant$58M